Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016

Hepatology International

Volumn 10, Issue 6, 2016, Pages 909-915

  Tanaka, Atsushi ^a   Ma, Xiong ^b   Yokosuka, Osamu ^c   Weltman, Martin ^d   You, Hong ^e   Amarapurkar, Deepak N ^f   Kim, Yoon Jun ^g   Abbas, Zaigham ^h   Payawal, Diana A ⁱ   Chang, Ming Ling ^j,k   Efe, Cumali ^l   Ozaslan, Ersan ^m   Abe, Masanori ⁿ   Mitchell Thain, Robert ^o   Zeniya, Mikio ^p   Han, Kwang Hyub ^q   Vierling, John M ^r   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHIBA UNIVERSITY   (Japan)

^d NEPEAN HOSPITAL   (Australia)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f BOMBAY HOSPITAL   (India)

^g Seoul National University College of Medicine   (South Korea)

^h ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

ⁱ Cardinal Santos Medical Center   (Philippines)

^j CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^k CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^l Batman Private World Hospital   (Turkey)

^m ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

ⁿ EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^o PBC Foundation   (United Kingdom)

^p Women's Medical Center of Sanno Medical Center   (Japan)

^q Yonsei University College of Medicine   (South Korea)

^r BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Autoimmune hepatitis; Autoimmune liver diseases; Epidemiology; Primary biliary cholangitis

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICOSTEROID; URSODEOXYCHOLIC ACID;

ACUTE LIVER FAILURE; ASIA; AUTOIMMUNE LIVER DISEASE; CELLULAR IMMUNITY; CHOLANGITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PREVALENCE; PRIMARY BILIARY CHOLANGITIS; PRIORITY JOURNAL; REVIEW; SURVIVAL; T LYMPHOCYTE; DISEASE MANAGEMENT; FEMALE; HEPATITIS, AUTOIMMUNE; JAPAN; LIVER CIRRHOSIS, BILIARY; MALE; MORTALITY; ORGANIZATION; PATHOLOGY; TAIWAN;

ASIA; CONGRESSES AS TOPIC; DISEASE MANAGEMENT; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; JAPAN; LIVER CIRRHOSIS, BILIARY; MALE; TAIWAN; URSODEOXYCHOLIC ACID;

EID: 84988642888     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-016-9767-9     Document Type: Review

References (39)

1. Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet 2013;382: 1433–1444
2. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51: 2193–2213
3. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31: 929–938
4. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48: 169–176
5. Kim BH, Kim YJ, Jeong SH, Tak WY, Ahn SH, Lee YJ, et al. Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study. J Gastroenterol Hepatol 2013;28: 128–134
6. Abe M, Mashiba T, Zeniya M, Yamamoto K, Onji M, Tsubouchi H, et al. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011;46: 1136–1141
7. Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 2011;54: 340–247
8. Amarapurkar D, Dharod M, Amarapurkar A. Autoimmune hepatitis in India: single tertiary referral centre experience. Troop Gastroenterol 2015;36: 36–45
9. Hassan N, Siddiqui A, Abbas Z, Hassan S, Soomro G, Mubarak M, et al. Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan. Hepat Mon 2013;13: e13598
10. Koay L, Lin C, Tsai S, Lee C, Lin C, Sheu M, et al. Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group. Dig Dis Sci 2006;51: 1978–1984
11. Yeh S, Ni Y, Jeng Y, Chen H, Wu J, Chang M. Emerging importance of autoimmune hepatitis in children in Taiwan, an endemic area for viral hepatitis. Pediatr Neonatol 2009;50: 65–69
12. Huang H, Huang Y, Wu J, Tsay S, Huo T, Wang Y, et al. Characteristics of autoimmune hepatitis in Taiwan: the 11 years’ experiences of a medical center. Zhonghua Yi Xue Za Zhi (Taipei) 2002;65: 563–569
13. Huo T, Wu J, Huang Y, Lai C, Tsay S, Lee S. Autoimmune hepatitis in an area endemic for hepatitis B virus infection: a report of three cases. Zhonghua Yi Xue Za Zhi (Taipei) 1996;57: 360–364
14. Huang H, Wu J, Huang Y, Teh-Ia H, Lo J, Li C, et al. Genetic distinctions and clinical characteristics of type 1 autoimmune hepatitis in Taiwan. Hepatogastroenterology 2008;55
15. Haider AS, Kaye G, Thomson A. Autoimmune hepatitis in a demographically isolated area of Australia. Int Med J 2010;40: 281–285
16. Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 2005;5: 27
17. Gohar S, Desai D, Joshi A, Bhaduri A, Deshpande R, Balkrishna C, et al. Autoimmune hepatitis: a study of 50 patients. Indian J Gastroenterol 2003;22: 140–142
18. Amarapurkar D, Patel N. Spectrum of autoimmune liver diseases in western India. J Gastroenterol Hepatol 2007;22: 2112–2117
19. Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 2004;127: 470–475
20. Liu H, Liu Y, Wang L, Xu D, Lin B, Zhong R, et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol 2010;10: 100
21. Sakauchi F, Mori M, Zeniya M, Toda G. A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 2005;15: 24–28
22. Kim KA, Ki M, Choi HY, Kim BH, Jang ES, Jeong SH. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther 2016;43: 154–162
23. he Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health LaWoJ. Guidelines for the management of primary biliary cirrhosis. Hepatol Res 2014;44 Suppl S1: 71–90
24. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51: 237–267
25. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, et al. Primary biliary cirrhosis. Hepatology 2009;50: 291–308
26. Chan CY, Lee SD, Huang YS, Wu JC, Tsai YT, Tsay SH, et al. Primary biliary cirrhosis in Taiwan. J Gastroenterol Hepatol 1990;5: 560-565
27. Hosonuma K, Sato K, Yamazaki Y, Yanagisawa M, Hashizume H, Horiguchi N, et al. A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia. Am J Gastroenterol 2015;110: 423–431
28. Chen CL, Yang JY, Lin SF, Sun CA, Bai CH, You SL, et al. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan. J Hepatol 2015;63: 354–363
29. Chien RN, Sheen IS, Liaw YF. Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: a case control study. J Gastroenterol Hepatol 1993;8: 574–576
30. Sui M, Wu R, Hu X, Zhang H, Jiang J, Yang Y, et al. Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population. J Viral Hepat 2014;21: 925–929
31. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54: 374–385
32. Bonder A, Retana A, Winston DM, Leung J, Kaplan MM. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2011;9: 609–612
33. Neuhauser M, Bjornsson E, Treeprasertsuk S, Enders F, Silveira M, Talwalkar J, et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010;105: 345–353
34. Yang F, Wang Q, Wang Z, Miao Q, Xiao X, Tang R, et al. The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis. Clin Rev Allergy Immunol 2016;50: 114–123
35. Chazouilleres O, Wendum D, Serfety L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28: 296–301
36. Efe C, Ozaslan E, Heurgue-Berlot A, Kav T, Masi C, Purnak T, et al. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol 2014;26: 532–537
37. Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 2002;35: 409–413
38. Tanaka A, Harada K, Ebinuma H, Komori A, Yokokawa J, Yoshizawa K, et al. Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res 2011;41: 877–886
39. Ozaslan E, Efe C, Heurgue-Berlot A, Kav T, Masi C, Purnak T, et al. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2014;12: 863–869